| Bos taurus |
Acetylcholinesterase |
IC50 |
30.0 |
nM |
10.1021/jm00109a009 |
| Bos taurus |
Acetylcholinesterase |
IC50 |
123.0 |
nM |
10.1016/s0960-894x(98)00076-6 |
| Bos taurus |
Acetylcholinesterase |
IC50 |
146.0 |
nM |
10.1016/s0960-894x(98)00076-6 |
| Bos taurus |
Acetylcholinesterase |
IC50 |
2580.0 |
nM |
10.1016/j.bmc.2010.01.074 |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Cavia porcellus |
Cavia porcellus |
pAI50 |
6.5 |
None |
10.1021/jm021055+ |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Muscarinic acetylcholine receptor M3 |
pA2 |
nan |
None |
10.1021/jm9810452 |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Danio rerio |
Danio rerio |
Activity |
nan |
None |
10.1021/acs.jnatprod.9b00563 |
| Danio rerio |
Danio rerio |
Activity |
nan |
None |
10.1038/nchembio.307 |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
0.034 |
ug.mL-1 |
10.1007/s00044-012-0325-2 |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
1.0 |
nM |
10.1016/S0960-894X(01)80432-7 |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
3.0 |
nM |
10.1021/acs.jnatprod.9b00233 |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
7.7 |
nM |
10.1016/j.ejmech.2014.05.002 |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
7.8 |
nM |
10.1021/acs.jnatprod.9b00563 |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
28.0 |
nM |
10.1021/jm00171a001 |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
40.0 |
nM |
10.1016/j.ejmech.2017.06.036 |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
41.0 |
nM |
10.1021/np000466v |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
41.0 |
nM |
10.1021/np020446o |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
46.0 |
nM |
10.1016/s0960-894x(98)00076-6 |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
53.0 |
nM |
10.1021/jm9014845 |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
61.0 |
nM |
10.1021/jm00120a008 |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
90.0 |
nM |
10.1016/j.bmc.2014.06.010 |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
90.0 |
nM |
10.1021/ml3001825 |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
103.0 |
nM |
10.1021/jm800564y |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
160.0 |
nM |
10.1016/j.bmc.2016.07.043 |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
275.0 |
nM |
10.1016/S0960-894X(00)80545-4 |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
1170.0 |
nM |
10.1039/c9md00559e |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
1500.0 |
nM |
10.1021/np960070c |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
53000.0 |
nM |
10.1021/jm00171a001 |
| Electrophorus electricus |
Acetylcholinesterase |
INH |
0.05 |
ug |
10.1021/np900644x |
| Electrophorus electricus |
Acetylcholinesterase |
Inhibition |
8.11 |
% |
10.1016/j.ejmech.2014.05.002 |
| Electrophorus electricus |
Acetylcholinesterase |
Inhibition |
87.0 |
% |
10.1021/np900644x |
| Electrophorus electricus |
Acetylcholinesterase |
Inhibition |
89.33 |
% |
10.1016/j.bmc.2012.09.040 |
| Electrophorus electricus |
Acetylcholinesterase |
Inhibition |
91.27 |
% |
10.1016/j.ejmech.2017.06.036 |
| Electrophorus electricus |
Acetylcholinesterase |
Inhibition |
94.0 |
% |
10.1021/np200814j |
| Electrophorus electricus |
Acetylcholinesterase |
Inhibition |
98.0 |
% |
10.1016/j.bmc.2020.115820 |
| Electrophorus electricus |
Acetylcholinesterase |
Inhibition |
99.8 |
% |
10.1021/acs.jnatprod.9b00563 |
| Electrophorus electricus |
Acetylcholinesterase |
Inhibition |
nan |
% |
10.1007/s00044-012-0325-2 |
| Electrophorus electricus |
Acetylcholinesterase |
K |
0.123 |
/min |
10.1016/j.bmc.2014.06.010 |
| Electrophorus electricus |
Acetylcholinesterase |
K |
34.3 |
nM |
10.1016/j.bmc.2014.06.010 |
| Electrophorus electricus |
Acetylcholinesterase |
Ki |
34.0 |
nM |
10.1021/ml3001825 |
| Electrophorus electricus |
Acetylcholinesterase |
Ki |
1000.0 |
nM |
10.1016/0960-894X(95)00179-W |
| Electrophorus electricus |
Acetylcholinesterase |
MIC |
0.1 |
ug |
10.1021/np200814j |
| Electrophorus electricus |
Acetylcholinesterase |
Relative potency |
100.0 |
% |
10.1021/jm00120a008 |
| Equus caballus |
Butyrylcholinesterase |
IC50 |
16.0 |
nM |
10.1016/s0960-894x(98)00484-3 |
| Equus caballus |
Butyrylcholinesterase |
IC50 |
73.0 |
nM |
10.1021/jm00043a012 |
| Equus caballus |
Butyrylcholinesterase |
IC50 |
3700.0 |
nM |
10.1016/j.bmc.2012.02.044 |
| Equus caballus |
Butyrylcholinesterase |
IC50 |
4666.7 |
nM |
10.1016/S0960-894X(00)80545-4 |
| Equus caballus |
Butyrylcholinesterase |
Ki |
nan |
None |
10.1016/j.bmc.2012.02.044 |
| Equus caballus |
Cholinesterase |
IC50 |
14.0 |
nM |
10.1016/j.bmc.2014.04.050 |
| Equus caballus |
Cholinesterase |
IC50 |
40.0 |
nM |
10.1016/j.bmc.2014.06.010 |
| Equus caballus |
Cholinesterase |
IC50 |
42.0 |
nM |
10.1021/ml3001825 |
| Equus caballus |
Cholinesterase |
IC50 |
60.0 |
nM |
10.1016/j.ejmech.2014.05.002 |
| Equus caballus |
Cholinesterase |
IC50 |
78.0 |
nM |
10.1021/acs.jmedchem.5b01674 |
| Equus caballus |
Cholinesterase |
IC50 |
220.0 |
nM |
10.1016/j.bmcl.2016.05.046 |
| Equus caballus |
Cholinesterase |
IC50 |
580.0 |
nM |
10.1016/j.bmc.2016.07.043 |
| Equus caballus |
Cholinesterase |
IC50 |
850.0 |
nM |
10.1016/j.ejmech.2017.06.036 |
| Equus caballus |
Cholinesterase |
IC50 |
857.0 |
nM |
10.1021/np000466v |
| Equus caballus |
Cholinesterase |
IC50 |
1340.0 |
nM |
10.1016/j.bmc.2010.01.074 |
| Equus caballus |
Cholinesterase |
Inhibition |
7.22 |
% |
10.1016/j.ejmech.2014.05.002 |
| Equus caballus |
Cholinesterase |
Inhibition |
82.82 |
% |
10.1016/j.ejmech.2017.06.036 |
| Equus caballus |
Cholinesterase |
Inhibition |
87.96 |
% |
10.1016/j.bmc.2012.09.040 |
| Equus caballus |
Cholinesterase |
Inhibition |
93.2 |
% |
10.1021/acs.jnatprod.9b00563 |
| Equus caballus |
Cholinesterase |
K |
0.067 |
/min |
10.1016/j.bmc.2014.06.010 |
| Equus caballus |
Cholinesterase |
K |
0.25 |
/hr |
10.1021/acs.jmedchem.5b01674 |
| Equus caballus |
Cholinesterase |
K |
0.3 |
/min |
10.1021/acs.jmedchem.5b01674 |
| Equus caballus |
Cholinesterase |
K |
41.0 |
nM |
10.1016/j.ejmech.2014.05.002 |
| Equus caballus |
Cholinesterase |
K |
41.1 |
nM |
10.1016/j.bmc.2014.06.010 |
| Equus caballus |
Cholinesterase |
K |
280.3 |
nM |
10.1021/acs.jmedchem.5b01674 |
| Equus caballus |
Cholinesterase |
Ki |
41.0 |
nM |
10.1021/ml3001825 |
| Equus caballus |
Cholinesterase |
Ratio |
0.3 |
/uM/min |
10.1021/acs.jmedchem.5b01674 |
| Gallus gallus |
Acetylcholinesterase |
IC50 |
20.0 |
nM |
10.1021/jm00187a027 |
| Giardia intestinalis |
Putative fructose-1,6-bisphosphate aldolase |
Potency |
15811.4 |
nM |
None |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
77.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
93.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Acetylcholinesterase |
Activity |
3.6 |
10'-4nmol |
10.1021/np900030y |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
0.008 |
ug.mL-1 |
10.1016/j.bmcl.2005.04.005 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
0.013 |
ug.mL-1 |
10.1007/s00044-011-9581-9 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
0.43 |
nM |
10.1021/jm00081a022 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
2.9 |
nM |
10.1016/j.bmcl.2013.04.081 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
13.49 |
nM |
10.1021/jm0494366 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
14.1 |
nM |
10.1021/jm010914b |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
14.13 |
nM |
10.1021/jm9810452 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
16.0 |
nM |
10.1016/j.ejmech.2021.114044 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
17.78 |
nM |
10.1021/jm000991r |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
17.78 |
nM |
10.1021/jm021055+ |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
18.9 |
nM |
10.1021/jm00007a005 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
18.97 |
nM |
10.1021/jm950704x |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
19.0 |
nM |
10.1021/jm00015a002 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
19.0 |
nM |
10.1021/jm00043a012 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
27.9 |
nM |
10.1016/j.bmc.2010.05.022 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
27.9 |
nM |
10.1021/jm970210v |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
27.9 |
nM |
10.1021/jm9800494 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
28.0 |
nM |
10.1016/j.ejmech.2022.114606 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
28.0 |
nM |
10.1021/jm010080x |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
28.0 |
nM |
10.1021/jm049309+ |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
28.0 |
nM |
10.1021/jm050578p |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
30.0 |
nM |
10.1016/0960-894X(95)00371-Y |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
30.0 |
nM |
10.1016/j.bmcl.2005.04.005 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
31.0 |
nM |
10.1021/jm00171a001 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
32.0 |
nM |
10.1021/acs.jmedchem.5b01674 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
35.0 |
nM |
10.1021/jm00171a001 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
40.0 |
nM |
10.1007/s00044-013-0847-2 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
40.0 |
nM |
10.1016/j.bmc.2015.06.051 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
43.0 |
nM |
10.1021/jm00084a015 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
43.0 |
nM |
10.1021/jm00095a008 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
47.0 |
nM |
10.1016/s0960-894x(98)00076-6 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
56.7 |
nM |
10.1021/jm100573q |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
57.0 |
nM |
10.1021/jm950771r |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
57.02 |
nM |
10.1021/jm970488n |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
61.0 |
nM |
10.1016/S0960-894X(00)80545-4 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
63.0 |
nM |
10.1021/acs.jnatprod.9b00561 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
80.0 |
nM |
10.1016/j.bmcl.2016.05.046 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
80.0 |
nM |
10.1016/j.ejmech.2020.112718 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
128.0 |
nM |
10.1016/S0960-894X(01)81088-X |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
128.0 |
nM |
10.1021/jm00039a013 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
128.0 |
nM |
10.1021/jm00086a011 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
150.0 |
nM |
10.1016/j.bmc.2012.02.044 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
160.0 |
nM |
10.1039/C1MD00221J |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
175.0 |
nM |
None |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
190.0 |
nM |
10.1039/d2md00262k |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
200.0 |
nM |
10.1016/j.bmcl.2021.128374 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
220.0 |
nM |
10.1016/j.bmc.2018.01.029 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
493.17 |
nM |
10.1016/j.bmcl.2006.08.067 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
500.0 |
nM |
10.1016/j.bmcl.2006.08.067 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
538.0 |
nM |
10.1021/acs.jnatprod.9b00759 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
3390.0 |
nM |
10.1016/j.ejmech.2021.113492 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
14000.0 |
nM |
10.1021/jm049515h |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
22000.0 |
nM |
10.1021/jm00171a001 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
25000.0 |
nM |
10.1021/jm00171a001 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
10.1021/jm0503289 |
| Homo sapiens |
Acetylcholinesterase |
Inhibition |
30.0 |
% |
10.1021/jm049515h |
| Homo sapiens |
Acetylcholinesterase |
Inhibition |
91.27 |
% |
10.1016/j.bmc.2015.06.051 |
| Homo sapiens |
Acetylcholinesterase |
Inhibition |
92.54 |
% |
10.1007/s00044-013-0847-2 |
| Homo sapiens |
Acetylcholinesterase |
Inhibition |
nan |
% |
10.1021/jm0494366 |
| Homo sapiens |
Acetylcholinesterase |
Inhibition |
nan |
% |
10.1021/jm0503289 |
| Homo sapiens |
Acetylcholinesterase |
IZ |
9.0 |
mm |
10.1016/j.ejmech.2020.112514 |
| Homo sapiens |
Acetylcholinesterase |
k3 |
9.0 |
min-1 |
10.1021/jm000991r |
| Homo sapiens |
Acetylcholinesterase |
Kc |
2.5e-07 |
M |
10.1021/jm000991r |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
10.1016/j.bmc.2012.02.044 |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
logIC50 |
1.45 |
None |
10.1021/jm100573q |
| Homo sapiens |
Acetylcholinesterase |
MIC |
3.6 |
10'-4nmol |
10.1021/np800806b |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Anandamide amidohydrolase |
Inhibition |
12.37 |
% |
10.1016/j.bmcl.2009.09.086 |
| Homo sapiens |
Anandamide amidohydrolase |
Inhibition |
18.85 |
% |
10.1016/j.bmcl.2009.09.086 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bile salt export pump |
IC50 |
1000000.0 |
nM |
10.1124/dmd.111.040758 |
| Homo sapiens |
Bloom syndrome protein |
Potency |
281.8 |
nM |
None |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Butyrylcholinesterase |
Activity |
0.41 |
uM |
10.1021/jm9014845 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
15.0 |
nM |
10.1021/jm00171a001 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
16.0 |
nM |
10.1016/j.bmc.2010.05.022 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
16.0 |
nM |
10.1016/j.ejmech.2021.114044 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
16.0 |
nM |
10.1016/j.ejmech.2022.114606 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
16.0 |
nM |
10.1021/jm010080x |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
16.0 |
nM |
10.1021/jm049309+ |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
16.0 |
nM |
10.1021/jm050578p |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
16.0 |
nM |
10.1021/jm970210v |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
16.0 |
nM |
10.1021/jm9800494 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
19.0 |
nM |
10.1021/jm9014845 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
22.91 |
nM |
10.1021/jm021055+ |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
22.91 |
nM |
10.1021/jm9810452 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
23.1 |
nM |
10.1021/jm010914b |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
26.3 |
nM |
10.1021/jm0494366 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
28.0 |
nM |
10.1021/jm800564y |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
35.0 |
nM |
10.1021/jm00084a015 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
35.0 |
nM |
10.1021/jm00095a008 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
73.0 |
nM |
10.1021/jm00007a005 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
73.0 |
nM |
10.1021/jm00015a002 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
129.0 |
nM |
10.1021/jm00171a001 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
130.0 |
nM |
10.1021/acs.jnatprod.9b00561 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
300.0 |
nM |
10.1016/j.bmcl.2021.128374 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
850.0 |
nM |
10.1007/s00044-013-0847-2 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
850.0 |
nM |
10.1016/j.bmc.2015.06.051 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
850.0 |
nM |
10.1016/j.ejmech.2019.07.059 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
857.0 |
nM |
10.1021/np020446o |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
930.0 |
nM |
10.1016/j.ejmech.2014.04.018 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
1164.13 |
nM |
10.1016/j.bmcl.2006.08.067 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
1200.0 |
nM |
10.1016/j.bmcl.2006.08.067 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
4000.0 |
nM |
10.1021/jm00171a001 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
23000.0 |
nM |
10.1021/jm049515h |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
26000.0 |
nM |
10.1021/jm00171a001 |
| Homo sapiens |
Butyrylcholinesterase |
IC50 |
4.365158322401666e+16 |
nM |
10.1021/jm000991r |
| Homo sapiens |
Butyrylcholinesterase |
Inhibition |
82.82 |
% |
10.1016/j.bmc.2015.06.051 |
| Homo sapiens |
Butyrylcholinesterase |
Inhibition |
92.54 |
% |
10.1007/s00044-013-0847-2 |
| Homo sapiens |
Butyrylcholinesterase |
Inhibition |
99.9 |
% |
10.1016/j.bmcl.2021.128374 |
| Homo sapiens |
Butyrylcholinesterase |
k3 |
70000.0 |
min-1 M-1 |
10.1021/jm00127a020 |
| Homo sapiens |
Butyrylcholinesterase |
Ki |
5000.0 |
nM |
10.1021/jm00127a020 |
| Homo sapiens |
Butyrylcholinesterase |
Ratio |
0.81 |
None |
10.1021/jm00084a015 |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cerebroside-sulfatase |
Potency |
37933.0 |
nM |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholinesterases; ACHE & BCHE |
Ratio |
0.8 |
None |
10.1021/jm00095a008 |
| Homo sapiens |
Cholinesterases; ACHE & BCHE |
Ratio |
1.6 |
None |
10.1021/jm010914b |
| Homo sapiens |
Cholinesterases; ACHE & BCHE |
Ratio |
1.6 |
None |
10.1021/jm049515h |
| Homo sapiens |
Cholinesterases; ACHE & BCHE |
Ratio |
1.6 |
None |
10.1021/jm9810046 |
| Homo sapiens |
Cholinesterases; ACHE & BCHE |
Ratio |
3.8 |
None |
10.1021/jm00043a012 |
| Homo sapiens |
Cholinesterases; ACHE & BCHE |
Ratio |
11.9 |
None |
10.1016/S0960-894X(00)80547-8 |
| Homo sapiens |
Cholinesterases; ACHE & BCHE |
Ratio |
11.9 |
None |
10.1021/jm00024a009 |
| Homo sapiens |
Cholinesterases; ACHE & BCHE |
Ratio IC50 |
1.7 |
None |
10.1016/j.bmc.2010.05.022 |
| Homo sapiens |
Cholinesterases; ACHE & BCHE |
Ratio IC50 |
2.0 |
None |
10.1021/jm050578p |
| Homo sapiens |
Cholinesterases; ACHE & BCHE |
Ratio IC50 |
2.4 |
None |
10.1016/j.bmcl.2006.08.067 |
| Homo sapiens |
Cholinesterases; ACHE & BCHE |
Ratio pIC50 |
2.0 |
None |
10.1021/jm0494366 |
| Homo sapiens |
Cholinesterases; ACHE & BCHE |
Selectivity |
1.0 |
None |
10.1021/jm021055+ |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
4296.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
200.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Geminin |
Potency |
1458.1 |
nM |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Glutaminase kidney isoform, mitochondrial |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Glutaminase kidney isoform, mitochondrial |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
16000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone acetyltransferase GCN5 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
13371.4 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Homo sapiens |
CL |
5.5 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL |
22.0 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL_renal |
16.5 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
0.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
F |
6.0 |
% |
10.1016/j.bmc.2007.08.060 |
| Homo sapiens |
Homo sapiens |
Fa |
0.05 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
F_fraction |
0.01 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fg |
0.26 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fh |
0.76 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
T1/2 |
0.5 |
hr |
10.1021/acs.jmedchem.6b00609 |
| Homo sapiens |
Homo sapiens |
Vdss |
0.66 |
L.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Isocitrate dehydrogenase [NADP] cytoplasmic |
Potency |
12995.3 |
nM |
None |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
2200.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Lysosomal acid lipase/cholesteryl ester hydrolase |
Inhibition |
nan |
% |
10.1021/jm100499s |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
M-phase phosphoprotein 8 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Mu opioid receptor |
AC50 |
5738.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
pA2 |
nan |
None |
10.1021/jm9810452 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
pA2 |
nan |
None |
10.1021/jm9810452 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
pKb |
nan |
None |
10.1021/jm021055+ |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
pKb |
nan |
None |
10.1021/jm0494366 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
68589.6 |
nM |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Plasma |
fCmax |
0.006 |
uM |
10.1124/dmd.111.040758 |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Prelamin-A/C |
Potency |
4.0 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Serum albumin |
pKa |
0.05 |
None |
10.1021/acs.jmedchem.0c00046 |
| Homo sapiens |
Serum albumin |
PPB |
9.7 |
% |
10.1021/acs.jmedchem.0c00046 |
| Homo sapiens |
Serum albumin |
PPB |
20.0 |
% |
10.1021/acs.jmedchem.0c00046 |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
78.13 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
80.76 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Survival motor neuron protein |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
9441.1 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Influenza A virus |
Nonstructural protein 1 |
Potency |
25118.9 |
nM |
None |
| Mus musculus |
Acetylcholinesterase |
IC50 |
0.68 |
nM |
10.1021/jm00024a009 |
| Mus musculus |
Acetylcholinesterase |
IC50 |
0.69 |
nM |
10.1021/jm00102a005 |
| Mus musculus |
Acetylcholinesterase |
IC50 |
40.0 |
nM |
10.1016/j.bmcl.2010.01.035 |
| Mus musculus |
Acetylcholinesterase |
IC50 |
40.0 |
nM |
10.1016/j.bmcl.2010.01.057 |
| Mus musculus |
Butyrylcholinesterase |
IC50 |
280.0 |
nM |
10.1016/j.bmcl.2010.01.035 |
| Mus musculus |
Butyrylcholinesterase |
IC50 |
280.0 |
nM |
10.1016/j.bmcl.2010.01.057 |
| Mus musculus |
Monoamine oxidase A |
Activity |
nan |
None |
10.1021/jm800656v |
| Mus musculus |
Muscarinic acetylcholine receptor M1 |
IC50 |
37000.0 |
nM |
10.1021/jm00084a015 |
| Mus musculus |
Muscarinic acetylcholine receptor M1 |
IC50 |
37000.0 |
nM |
10.1021/jm00095a008 |
| Mus musculus |
Muscarinic acetylcholine receptor M2 |
IC50 |
160000.0 |
nM |
10.1021/jm00084a015 |
| Mus musculus |
Muscarinic acetylcholine receptor M2 |
Ratio |
4.4 |
None |
10.1021/jm00084a015 |
| Mus musculus |
Mus musculus |
Approx. lethal dose |
0.8 |
None |
10.1021/jm00095a008 |
| Mus musculus |
Mus musculus |
Change |
144.0 |
% |
10.1021/jm00084a015 |
| Mus musculus |
Mus musculus |
Change from control |
1444.4 |
% |
10.1021/jm00095a008 |
| Mus musculus |
Mus musculus |
DOSE |
0.32 |
mg.kg-1 |
10.1021/jm00039a013 |
| Mus musculus |
Mus musculus |
ED50 |
0.0076 |
umol.kg-1 |
10.1021/jm00109a009 |
| Mus musculus |
Mus musculus |
ED50 |
0.02 |
umol.kg-1 |
10.1021/jm00164a017 |
| Mus musculus |
Mus musculus |
ED50 |
0.3 |
mg.kg-1 |
10.1021/jm00031a019 |
| Mus musculus |
Mus musculus |
ED50 |
0.5 |
mg.kg-1 |
10.1021/jm00031a019 |
| Mus musculus |
Mus musculus |
Improvement |
36.0 |
% |
10.1016/S0960-894X(01)81101-X |
| Mus musculus |
Mus musculus |
LD50 |
0.6 |
mg.kg-1 |
10.1021/jm00031a019 |
| Mus musculus |
Mus musculus |
LD50 |
0.88 |
mg.kg-1 |
10.1021/jm00039a013 |
| Mus musculus |
Mus musculus |
LD50 |
0.88 |
mg.kg-1 |
10.1021/jm00086a011 |
| Mus musculus |
Mus musculus |
LD50 |
1.2 |
umol.kg-1 |
10.1021/jm00164a017 |
| Mus musculus |
Mus musculus |
Lethal dose |
0.8 |
mg kg-1 |
10.1021/jm00084a015 |
| Mus musculus |
Mus musculus |
PD50 |
0.02 |
uM kg-1 |
10.1021/jm00109a009 |
| Mus musculus |
Mus musculus |
Retention |
35.0 |
% |
10.1021/jm00135a020 |
| Mus musculus |
Mus musculus |
Retention |
45.0 |
% |
10.1021/jm00135a020 |
| Mus musculus |
Mus musculus |
Retention |
nan |
None |
10.1021/jm00135a020 |
| Mus musculus |
Mus musculus |
Survival |
60.0 |
% |
10.1016/S0960-894X(01)80216-X |
| Mus musculus |
Mus musculus |
Survival |
60.0 |
% |
10.1016/S0960-894X(01)80217-1 |
| Mus musculus |
Mus musculus |
Survival |
60.0 |
% |
10.1016/S0960-894X(01)81101-X |
| Mus musculus |
Mus musculus |
Therapeutic index |
40.0 |
None |
10.1021/jm00109a009 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
3981.07 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
5011.87 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
6309.57 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
2685.5 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
3380.8 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
10417.9 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
13115.4 |
nM |
None |
| Rattus norvegicus |
Acetylcholinesterase |
Activity |
nan |
None |
10.1016/S0960-894X(00)80547-8 |
| Rattus norvegicus |
Acetylcholinesterase |
IC50 |
0.68 |
nM |
10.1016/S0960-894X(00)80547-8 |
| Rattus norvegicus |
Acetylcholinesterase |
IC50 |
1.0 |
nM |
10.1016/j.bmcl.2010.01.097 |
| Rattus norvegicus |
Acetylcholinesterase |
IC50 |
2.0 |
nM |
10.1021/jm9810046 |
| Rattus norvegicus |
Acetylcholinesterase |
IC50 |
11.0 |
nM |
10.1016/j.bmc.2012.06.048 |
| Rattus norvegicus |
Acetylcholinesterase |
IC50 |
14.0 |
nM |
10.1021/jm9810046 |
| Rattus norvegicus |
Acetylcholinesterase |
IC50 |
80.0 |
nM |
10.1021/jm00015a020 |
| Rattus norvegicus |
Acetylcholinesterase |
IC50 |
190.0 |
nM |
10.1021/jm00031a019 |
| Rattus norvegicus |
Acetylcholinesterase |
ID50 |
0.2 |
mg.kg-1 |
10.1021/jm00031a019 |
| Rattus norvegicus |
Acetylcholinesterase |
ID50 |
1.0 |
mg.kg-1 |
10.1021/jm00031a019 |
| Rattus norvegicus |
Acetylcholinesterase |
Inhibition |
nan |
% |
10.1016/j.bmc.2012.06.048 |
| Rattus norvegicus |
Acetylcholinesterase and butyrylcholinesterase (AChE and BChE) |
Ratio IC50 |
7.0 |
None |
10.1016/j.bmcl.2010.01.097 |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Bile salt export pump |
IC50 |
1000000.0 |
nM |
10.1124/dmd.111.040758 |
| Rattus norvegicus |
Butyrylcholinesterase |
IC50 |
7.6 |
nM |
10.1016/j.bmcl.2010.01.097 |
| Rattus norvegicus |
Butyrylcholinesterase |
IC50 |
8.1 |
nM |
10.1016/S0960-894X(00)80547-8 |
| Rattus norvegicus |
Butyrylcholinesterase |
IC50 |
8.1 |
nM |
10.1021/jm00024a009 |
| Rattus norvegicus |
Butyrylcholinesterase |
IC50 |
8.1 |
nM |
10.1021/jm00102a005 |
| Rattus norvegicus |
Butyrylcholinesterase |
IC50 |
23.0 |
nM |
10.1021/jm9810046 |
| Rattus norvegicus |
Butyrylcholinesterase |
IC50 |
58.4 |
nM |
10.1016/j.bmc.2012.06.048 |
| Rattus norvegicus |
Butyrylcholinesterase |
Inhibition |
nan |
% |
10.1016/j.bmc.2012.06.048 |
| Rattus norvegicus |
Butyrylcholinesterase |
Ratio |
11.7 |
None |
10.1021/jm00102a005 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M2 |
IC50 |
160000.0 |
nM |
10.1021/jm00095a008 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M2 |
Ratio |
4.3 |
None |
10.1021/jm00095a008 |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
18105.6 |
nM |
None |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
25099.9 |
nM |
None |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
40300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
41700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
43300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
305.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
342.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
370.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
416.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
50.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
52.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
56.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
64.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
80.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
86.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
87.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
99.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASO |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASOLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
1.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
1.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Biodistribution |
0.2 |
% |
10.1021/jm9910223 |
| Rattus norvegicus |
Rattus norvegicus |
Biodistribution |
0.4 |
% |
10.1021/jm9910223 |
| Rattus norvegicus |
Rattus norvegicus |
Biodistribution |
0.5 |
% |
10.1021/jm9910223 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
146.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
150.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
153.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
220.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
102.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
104.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
105.33 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
107.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
600.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
623.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
673.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
786.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
187.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
226.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
386.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
479.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
24000000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
24670000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
26000000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
27670000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
40.0 |
% |
10.1021/jm00031a019 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
79.0 |
% |
10.1021/jm00031a019 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
135.0 |
% |
10.1021/jm00031a019 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
152.0 |
% |
10.1021/jm00031a019 |
| Rattus norvegicus |
Rattus norvegicus |
Control |
286.0 |
% |
10.1021/jm00031a019 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.4 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.2 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
107.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
138.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
171.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
271.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
1.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
1.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
2.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1593.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1616.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1680.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1810.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
32.57 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
33.77 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
34.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
35.8 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
122700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
130000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
132700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
135700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Ileal activity |
0.005 |
uM |
10.1021/jm00084a015 |
| Rattus norvegicus |
Rattus norvegicus |
Ileal activity |
0.005 |
uM |
10.1021/jm00095a008 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
93.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
95.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
115.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
200.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
7.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
8.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
8.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
8706.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
10987.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
11715.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
16178.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
68.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
84.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
86.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
88.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.8 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.03 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.13 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.43 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
376700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
379000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
385700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
387000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
62.37 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
62.8 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
63.27 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
64.1 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
43.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
71.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
88.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
247.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
0.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
0.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
10.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
10.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
14.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
29.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1134.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1491.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
2735.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
3645.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
123.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
133.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
133.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
139.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1062000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1091000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1231000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1244330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.92 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.09 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.15 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.49 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
57300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
58300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
61700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
64300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5080000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5420000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5700000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.0 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
141.5 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
144.47 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
146.53 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
147.9 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
12.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
14.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
16.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
17.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
12300.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
12570.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
13570.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
19300.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
29934.9 |
nM |
None |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.353 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Torpedo californica |
Acetylcholinesterase |
IC50 |
11.0 |
nM |
10.1016/j.bmc.2014.04.050 |
| Torpedo californica |
Acetylcholinesterase |
IC50 |
46.0 |
nM |
10.1016/s0960-894x(98)00076-6 |
| None |
ADMET |
K3 |
0.41 |
min-1 |
10.1021/jm010914b |
| None |
ADMET |
K5 |
0.43 |
hr-1 |
10.1021/jm010914b |
| None |
ADMET |
Kc |
33.5 |
nM |
10.1021/jm010914b |
| None |
ADMET |
pKa |
nan |
None |
10.1021/jm021055+ |
| None |
ADMET |
T1/2 |
1.0 |
hr |
10.1021/jm970210v |
| None |
ADMET |
Therapeutic index |
60.0 |
None |
10.1021/jm00164a017 |
| None |
Hepatotoxicity |
DILI positive/negative |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx1000865 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1124/dmd.110.035113 |
| None |
NON-PROTEIN TARGET |
Anticonvulsant activity |
nan |
None |
10.1016/s0960-894x(03)00535-3 |
| None |
NON-PROTEIN TARGET |
Potency |
3981.1 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
4466.8 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
5011.9 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
7079.5 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
7943.3 |
nM |
None |
| None |
No relevant target |
Log PNalk |
-0.46 |
None |
10.1021/jm048980b |
| None |
No relevant target |
Peff |
nan |
None |
10.1021/acs.jnatprod.9b00561 |
| None |
No relevant target |
pKa |
7.9 |
None |
10.1016/S0960-894X(01)80432-7 |
| None |
No relevant target |
pKa |
8.17 |
None |
10.1007/s11095-013-1232-z |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1021/ci6004542 |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1021/mp100103e |
| None |
Unchecked |
Ac50 |
19.95 |
uM |
None |
| None |
Unchecked |
Ac50 |
39.81 |
uM |
None |
| None |
Unchecked |
Ac50 |
44.67 |
uM |
None |
| None |
Unchecked |
AC50 |
19952.6 |
nM |
None |
| None |
Unchecked |
AC50 |
39810.7 |
nM |
None |
| None |
Unchecked |
AC50 |
44668.4 |
nM |
None |
| None |
Unchecked |
Activity |
13.0 |
% |
10.1021/np50034a023 |
| None |
Unchecked |
IC50 |
360.0 |
nM |
10.1021/jm030605g |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1038/nchembio873 |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Potency |
281.8 |
nM |
None |
| None |
Unchecked |
Potency |
3548.1 |
nM |
None |
| None |
Unchecked |
Potency |
10000.0 |
nM |
None |
| None |
Unchecked |
Potency |
11220.2 |
nM |
None |
| None |
Unchecked |
Potency |
15848.9 |
nM |
None |
| None |
Unchecked |
Ratio |
2.7 |
None |
10.1021/jm9014845 |
| None |
Unchecked |
Ratio |
3.8 |
None |
10.1021/jm00015a002 |
| None |
Unchecked |
Ratio IC50 |
0.047 |
None |
10.1021/np020446o |
| None |
Unchecked |
Ratio IC50 |
0.13 |
None |
10.1016/j.ejmech.2014.05.002 |
| None |
Unchecked |
Ratio IC50 |
0.14 |
None |
10.1016/j.bmcl.2010.01.035 |
| None |
Unchecked |
Ratio IC50 |
0.14 |
None |
10.1016/j.bmcl.2010.01.057 |
| None |
Unchecked |
Ratio IC50 |
0.28 |
None |
10.1016/j.bmc.2016.07.043 |
| None |
Unchecked |
Ratio IC50 |
0.36 |
None |
10.1016/j.bmcl.2016.05.046 |
| None |
Unchecked |
Ratio IC50 |
0.48 |
None |
10.1021/acs.jnatprod.9b00561 |
| None |
Unchecked |
Ratio IC50 |
0.519 |
None |
10.1016/j.bmc.2010.01.074 |
| None |
Unchecked |
Ratio IC50 |
2.1 |
None |
10.1021/ml3001825 |
| None |
Unchecked |
Ratio IC50 |
2.14 |
None |
10.1016/j.bmc.2014.06.010 |
| None |
Unchecked |
Ratio IC50 |
2.75 |
None |
10.1016/j.bmcl.2016.05.046 |
| None |
Unchecked |
Ratio IC50 |
3.63 |
None |
10.1016/j.bmc.2016.07.043 |
| None |
Unchecked |
Ratio IC50 |
3.7 |
None |
10.1021/jm800564y |
| None |
Unchecked |
Ratio IC50 |
5.3 |
None |
10.1016/j.bmc.2012.06.048 |
| None |
Unchecked |
Relative potency |
0.37 |
None |
10.1021/jm00109a009 |
| None |
Unchecked |
Selectivity Index |
0.67 |
None |
10.1016/j.bmcl.2021.128374 |
| None |
Unchecked |
Selectivity Index |
1.5 |
None |
10.1016/j.bmcl.2021.128374 |